134 related articles for article (PubMed ID: 30273784)
1. Serum cytokine profiles in patients with chronic obstructive pulmonary disease associated pulmonary hypertension identified using protein array.
Zhang Y; Lin P; Hong C; Jiang Q; Xing Y; Tang X; Jiang H; Luo S; Chen X
Cytokine; 2018 Nov; 111():342-349. PubMed ID: 30273784
[TBL] [Abstract][Full Text] [Related]
2. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
[TBL] [Abstract][Full Text] [Related]
3. Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease.
Bade G; Khan MA; Srivastava AK; Khare P; Solaiappan KK; Guleria R; Palaniyar N; Talwar A
Int J Chron Obstruct Pulmon Dis; 2014; 9():759-73. PubMed ID: 25125975
[TBL] [Abstract][Full Text] [Related]
4. Systemic inflammation in patients with COPD and pulmonary hypertension.
Joppa P; Petrasova D; Stancak B; Tkacova R
Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
[TBL] [Abstract][Full Text] [Related]
5. Change of Serum Inflammatory Cytokines Levels in Patients With Chronic Obstructive Pulmonary Disease, Pneumonia and Lung Cancer.
Chen J; Li X; Huang C; Lin Y; Dai Q
Technol Cancer Res Treat; 2020; 19():1533033820951807. PubMed ID: 33111646
[TBL] [Abstract][Full Text] [Related]
6. Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive pulmonary disease?
Telo S; Kırkıl G; Kuluöztürk M; Balin M; Deveci F
Clin Respir J; 2018 Apr; 12(4):1433-1438. PubMed ID: 28756635
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
[TBL] [Abstract][Full Text] [Related]
8. The prognosis value of C-reactive protein and endothelin-1 in chronic obstructive pulmonary disease patients with pulmonary artery pressure.
Yan F; Pidayi M; Xia Y; Hu X; Yang Z
Pak J Pharm Sci; 2019 Jul; 32(4):1697-1701. PubMed ID: 31608892
[TBL] [Abstract][Full Text] [Related]
9. High levels of interleukin-6 and 8-iso-prostaglandin in the exhaled breath condensate and serum of patients with chronic obstructive pulmonary disease related pulmonary hypertension.
He H; Tao Y; Chen X; Qiu H; Zhu J; Zhang J; Ma H
Chin Med J (Engl); 2014; 127(9):1608-12. PubMed ID: 24791862
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between serum marker variations and pulmonary hypertension secondary to chronic obstructive pulmonary disease].
Xie X; Wang X; Zhang Y; Han D; Li S; Li M
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1458-62. PubMed ID: 24144746
[TBL] [Abstract][Full Text] [Related]
11. Multiple Circulating Cytokines Are Coelevated in Chronic Obstructive Pulmonary Disease.
Selvarajah S; Todd I; Tighe PJ; John M; Bolton CE; Harrison T; Fairclough LC
Mediators Inflamm; 2016; 2016():3604842. PubMed ID: 27524865
[TBL] [Abstract][Full Text] [Related]
12. Increased Plasma Level of miR-210 as a Potential Diagnostic Marker for Chronic Obstructive Pulmonary Disease Induced Pulmonary Hypertension.
Huang H; Wu F; Yang J; Li H; Cai M; Shan K; Shi S
Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538057
[TBL] [Abstract][Full Text] [Related]
13. Mean platelet volume as a predictor of pulmonary hypertension in patients with stable COPD.
Mohamed MF; Ali A; Abbas A; Awad MS; Gouda M; Sediq AM
Int J Chron Obstruct Pulmon Dis; 2019; 14():1099-1108. PubMed ID: 31213790
[No Abstract] [Full Text] [Related]
14. Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension.
Wang L; Jin YZ; Zhao QH; Jiang R; Wu WH; Gong SG; He J; Liu JM; Jing ZC
Int J Chron Obstruct Pulmon Dis; 2017; 12():3353-3360. PubMed ID: 29200842
[TBL] [Abstract][Full Text] [Related]
15. Association of brain natriuretic peptide gene polymorphisms with chronic obstructive pulmonary disease complicated with pulmonary hypertension and its mechanism.
Jin G; Chen Z; Zhang J; Song J; Shi J; Zhou B
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30217946
[No Abstract] [Full Text] [Related]
16. Echocardiographic Evaluation of the Relationship Between inflammatory factors (IL6, TNFα, hs-CRP) and Secondary Pulmonary Hypertension in patients with COPD. A Cross sectional study.
Ansarin K; Rashidi F; Namdar H; Ghaffari M; Sharifi A
Pneumologia; 2015; 64(3):31-5. PubMed ID: 26738368
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of trace minerals and heavy metals in severe COPD patients with and without pulmonary hypertension.
Asker S; Asker M; Yeltekin AC; Aslan M; Ozbay B; Demir H; Turan H
Int J Chron Obstruct Pulmon Dis; 2018; 13():1803-1808. PubMed ID: 29910610
[TBL] [Abstract][Full Text] [Related]
18. Serum CA-125 level in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension.
Rahimi-Rad MH; Rahimi P; Rahimi B; Gholamnaghad M
Pneumologia; 2014; 63(3):164-6. PubMed ID: 25420291
[TBL] [Abstract][Full Text] [Related]
19. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease.
Mandal J; Roth M; Costa L; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
Respiration; 2015; 90(5):357-68. PubMed ID: 26447811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
